AP2013007271A0 - Point-of-care, medical condition screening kit - Google Patents

Point-of-care, medical condition screening kit

Info

Publication number
AP2013007271A0
AP2013007271A0 AP2013007271A AP2013007271A AP2013007271A0 AP 2013007271 A0 AP2013007271 A0 AP 2013007271A0 AP 2013007271 A AP2013007271 A AP 2013007271A AP 2013007271 A AP2013007271 A AP 2013007271A AP 2013007271 A0 AP2013007271 A0 AP 2013007271A0
Authority
AP
ARIPO
Prior art keywords
care
point
medical condition
screening kit
condition screening
Prior art date
Application number
AP2013007271A
Other languages
English (en)
Inventor
Sean Mongale
Mary O'grady
James Waring Iii
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of AP2013007271A0 publication Critical patent/AP2013007271A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y10T436/144444—Glucose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173076—Nitrite or nitrate
AP2013007271A 2011-05-06 2012-05-07 Point-of-care, medical condition screening kit AP2013007271A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161483482P 2011-05-06 2011-05-06
US201161563281P 2011-11-23 2011-11-23
US201161563274P 2011-11-23 2011-11-23
US201161563285P 2011-11-23 2011-11-23
PCT/US2012/036776 WO2012154672A2 (en) 2011-05-06 2012-05-07 Point-of-care, medical condition screening kit

Publications (1)

Publication Number Publication Date
AP2013007271A0 true AP2013007271A0 (en) 2013-11-30

Family

ID=47139927

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007271A AP2013007271A0 (en) 2011-05-06 2012-05-07 Point-of-care, medical condition screening kit

Country Status (5)

Country Link
US (1) US8808981B2 (zh)
CN (1) CN103649749A (zh)
AP (1) AP2013007271A0 (zh)
SG (1) SG194797A1 (zh)
WO (1) WO2012154672A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2897931T3 (es) 2014-10-14 2022-03-03 Becton Dickinson Co Gestión de muestras de sangre utilizando espuma de célula abierta
BR122020024283B1 (pt) * 2014-10-14 2023-02-23 Becton, Dickinson And Company Dispositivo de transferência de sangue adaptado para receber uma amostra de sangue
MX2017002125A (es) 2015-03-10 2017-05-12 Becton Dickinson Co Dispositivo de gestion de micromuestras de fluido biologico.
CN105675603B (zh) * 2015-05-16 2018-07-06 乔爱军 一种临床症状筛查试剂盒
CN104807986B (zh) * 2015-05-16 2016-06-29 青岛市市立医院 临床医学症状筛查试剂盒
JP2018536142A (ja) 2015-09-01 2018-12-06 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 試料の相を分離するためのデプスフィルトレーションデバイス
CN106645120B (zh) * 2016-11-21 2019-01-15 江苏华鸣生物科技有限公司 检测尿液中单羟酚类代谢物的试剂盒及其制备方法
US11176318B2 (en) 2017-05-18 2021-11-16 International Business Machines Corporation Medical network
US11953496B2 (en) * 2019-08-19 2024-04-09 Hach Company Chemistry/instrument parameter color maintenance

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154081A0 (en) * 2000-07-31 2003-07-31 Lifescan Inc Method and apparatus for detecting the presence of a fluid on a test strip
US20030013121A1 (en) * 2001-07-12 2003-01-16 Khan Waheed N. Diagnostic test kit
US20050214161A1 (en) * 2004-03-23 2005-09-29 Gupta Surendra K Test device for simultaneous measurement of multiple analytes in a single sample
US20060263244A1 (en) * 2005-05-04 2006-11-23 Rannikko Minna A Devices, systems, and methods for the containment and use of liquid solutions
US20080261326A1 (en) * 2007-04-23 2008-10-23 Christie Dudenhoefer Drop-on-demand manufacturing of diagnostic test strips
US20080300508A1 (en) * 2007-05-30 2008-12-04 Inverness Medical Switzerland Gmbh Diagnostic patch
US20100159599A1 (en) * 2008-12-18 2010-06-24 Xuedong Song Lateral-flow porous membrane assay with flow rate control
EP2278334A1 (en) * 2009-07-22 2011-01-26 Etablissement Francais du Sang A membrane based microarray device for high-throughput multianalyte detection
CN201565306U (zh) * 2009-07-24 2010-09-01 北京滨松光子技术股份有限公司 样品测试装置
US20110076206A1 (en) * 2009-09-29 2011-03-31 Yue Yao Reagent containers for compact test devices
CA2846247A1 (en) * 2011-09-16 2013-03-21 Credo Biomedical Pte Ltd Molecular diagnostic assay device and method of use

Also Published As

Publication number Publication date
CN103649749A (zh) 2014-03-19
WO2012154672A3 (en) 2013-01-10
US8808981B2 (en) 2014-08-19
US20140093896A1 (en) 2014-04-03
SG194797A1 (en) 2013-12-30
WO2012154672A2 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
IL239262A0 (en) Scanning methods
EP2685807A4 (en) SCREENING METHODS
GB201216143D0 (en) .
AP2013007271A0 (en) Point-of-care, medical condition screening kit
GB201203412D0 (en) .
PL2602805T3 (pl) Obudowa urządzenia zabezpieczającego przed przepięciami i urządzenie zabezpieczające przed takimi przepięciami
EP2841942A4 (en) Preeclampsia SCREENING PROCESS
GB201203063D0 (en) .
IL227377A0 (en) Combinations
IL225312A0 (en) New combinations
GB201117172D0 (en) Diabetes
GB201104556D0 (en) Biomarkers
HK1191942A1 (zh) 新型六氫環戊二烯並吡咯酮，六氫吡咯並吡咯酮，八氫吡咯並吡啶酮和八氫吡啶酮化合物
GB201213770D0 (en) Screening methods
GB201216122D0 (en) Screening assay
GB201202620D0 (en) .
GB2496061B (en) Multi Purpose colander
PL2612712T3 (pl) Sito
GB201105572D0 (en) Screening method-III
GB201202870D0 (en) Screening methods
GB201112355D0 (en) DNA screening
IL213578A0 (en) Sifter kit
GB201203786D0 (en) .
GB201204535D0 (en) .
GB201120548D0 (en) .